Condition
Acute Liver Failure clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Acute Liver Failure clinical trials that are recruiting, at sites in 16 countries (most in Austria (2), Germany (2), Italy (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 16Countries
Newest Acute Liver Failure clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| N-acetylcysteine for non-acetaminophen-induced acute liver failure | — | Lahore, Punjab Province | Recruiting | Aug 14, 2026 |
| Reference framework for outcomes after machine-preserved liver transplantation in Europe | — | Innsbruck and 37 other locations | Recruiting | May 14, 2026 |
| Combined DPMAS (double plasma molecular adsorption) and therapeutic plasma exchange to improve clotting, reduce inflammation, and support organs in acute liver failure | — | Prague | Recruiting | Jan 9, 2026 |
| Standard-volume versus high-volume plasma exchange for children with acute liver failure | — | New Delhi, National Capital Territory of Delhi | Recruiting | Feb 18, 2025 |
| F573 injection for treating liver injury and failure | Phase 2 | Beijing, Beijing Municipality and 9 other locations | Recruiting | Jan 19, 2023 |
| Registry for monitoring CytoSorb device use in critically ill patients | — | Klagenfurt and 27 other locations | Recruiting | Dec 6, 2021 |
All recruiting trials (6)
-
N-acetylcysteine for non-acetaminophen-induced acute liver failure
Researchers are testing whether adding oral N-acetylcysteine to standard care helps adults with non-acetaminophen acute liver failure survive longer compared with standard care alone.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
-
Combined DPMAS (double plasma molecular adsorption) and therapeutic plasma exchange to improve clotting, reduce inflammation, and support organs in acute liver failure
We will test whether combining DPMAS (double plasma molecular adsorption) with therapeutic plasma exchange (TPE) helps adults in the ICU with acute liver failure or acute-on-chronic liver failure recover organ function or safely reach a transplant.
-
Standard-volume versus high-volume plasma exchange for children with acute liver failure
This trial will see if using high-volume plasma exchange instead of standard-volume plasma exchange helps children (ages 3–18) with acute liver failure keep their native liver.
-
F573 injection for treating liver injury and failure
This study is testing if an injection called F573 can help people with liver injury or chronic hepatitis B feel better and recover.
-
Registry for monitoring CytoSorb device use in critically ill patients
This study is collecting information on how the CytoSorb device helps critically ill patients to improve care for conditions like septic shock and acute respiratory distress syndrome.
Related topics
Quick answers
How many Acute Liver Failure clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in Austria (2 trials), Germany (2 trials), Italy (2 trials), Spain (2 trials), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.